Efficacy and Safety of Rapid Titration Protocols of Lacosamide

• Status: Completed
• Trial end date: 2019-06-07
• Target enrollment: 0
• Participant gender: All

Summary

Three different dose titration schedules are tested to find a way to reduce the titration period of lacosamide

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborators: Dongsan Medical Center; Konkuk University
• Treatments: Lacosamide

Criteria

Inclusion Criteria:

• Adults aged 18-85 years old

• Patients diagnosed with focal epilepsy

• Patients subjected to the addition of lacosamide to treat focal onset seizures according to physician's judgement

• Subjects provided informed consent

Exclusion Criteria:

• Subjects who changed other antiepileptic drugs at the beginning of lacosamide treatment

• Subjects with unstable physical, mental or other disease condition that can impede with accurate evaluation or treatment

• Subjects with terminal illness or general medical condition that can impede with the participation of the clinical trial

• Subjects who do not agree with prior consent